Jatcorp Ltd
ASX:JAT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jatcorp Ltd
ASX:JAT
|
AU |
|
Bukwang Pharm Co Ltd
KRX:003000
|
KR |
|
Piesat Information Technology Co Ltd
SSE:688066
|
CN |
|
Nanjing Develop Advanced Manufacturing Co Ltd
SSE:688377
|
CN |
|
Cosan SA
NYSE:CSAN
|
BR |
Balance Sheet
Balance Sheet Decomposition
Jatcorp Ltd
Jatcorp Ltd
Balance Sheet
Jatcorp Ltd
| Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
3
|
2
|
1
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
4
|
8
|
11
|
6
|
4
|
4
|
2
|
3
|
|
| Cash |
1
|
3
|
2
|
1
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
4
|
4
|
2
|
3
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
8
|
11
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
7
|
6
|
4
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
6
|
1
|
2
|
8
|
5
|
5
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
4
|
0
|
0
|
1
|
2
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
1
|
2
|
6
|
3
|
4
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
5
|
4
|
5
|
5
|
4
|
5
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
1
|
|
| Total Current Assets |
1
|
10
|
8
|
4
|
4
|
1
|
3
|
2
|
2
|
1
|
0
|
8
|
16
|
23
|
12
|
11
|
16
|
12
|
13
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
9
|
9
|
7
|
11
|
9
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
11
|
9
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
|
| Intangible Assets |
0
|
2
|
0
|
0
|
0
|
4
|
2
|
0
|
0
|
0
|
0
|
24
|
3
|
15
|
1
|
1
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
26
|
12
|
6
|
2
|
2
|
2
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
1
|
2
|
0
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
26
|
12
|
6
|
2
|
2
|
2
|
0
|
|
| Total Assets |
1
N/A
|
13
+1 278%
|
9
-31%
|
5
-50%
|
10
+125%
|
6
-45%
|
5
-11%
|
2
-55%
|
2
-25%
|
1
-65%
|
0
-70%
|
32
+17 313%
|
45
+41%
|
58
+30%
|
29
-51%
|
23
-20%
|
26
+15%
|
25
-4%
|
23
-11%
|
|
| Liabilities | ||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
6
|
4
|
6
|
2
|
2
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
0
|
2
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
13
|
7
|
2
|
2
|
2
|
2
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
6
|
2
|
1
|
0
|
8
|
3
|
7
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
3
|
9
|
23
|
13
|
10
|
13
|
9
|
13
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
12
|
5
|
5
|
2
|
5
|
5
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
5
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
12
|
15
|
12
|
5
|
1
|
2
|
3
|
2
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+720%
|
0
-59%
|
0
+82%
|
0
+13%
|
0
-63%
|
1
+738%
|
1
+20%
|
1
-13%
|
1
+27%
|
1
-36%
|
17
+1 711%
|
27
+62%
|
52
+89%
|
23
-55%
|
16
-32%
|
18
+13%
|
17
-5%
|
17
-4%
|
|
| Equity | ||||||||||||||||||||
| Common Stock |
1
|
18
|
17
|
17
|
26
|
26
|
26
|
27
|
27
|
28
|
28
|
45
|
58
|
64
|
78
|
86
|
90
|
90
|
90
|
|
| Retained Earnings |
0
|
5
|
8
|
13
|
16
|
20
|
22
|
26
|
27
|
29
|
29
|
30
|
40
|
58
|
73
|
79
|
82
|
82
|
84
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
13
+1 309%
|
9
-30%
|
4
-53%
|
10
+133%
|
6
-44%
|
4
-28%
|
1
-76%
|
1
-42%
|
1
N/A
|
1
+13%
|
15
N/A
|
17
+17%
|
6
-63%
|
5
-21%
|
7
+35%
|
8
+21%
|
8
-1%
|
6
-26%
|
|
| Total Liabilities & Equity |
1
N/A
|
13
+1 278%
|
9
-31%
|
5
-50%
|
10
+125%
|
6
-45%
|
5
-11%
|
2
-55%
|
2
-25%
|
1
-65%
|
0
-70%
|
32
+17 313%
|
45
+41%
|
58
+30%
|
29
-51%
|
23
-20%
|
26
+15%
|
25
-4%
|
23
-11%
|
|
| Shares Outstanding | ||||||||||||||||||||
| Common Shares Outstanding |
11
|
38
|
33
|
33
|
87
|
90
|
112
|
118
|
151
|
180
|
224
|
603
|
818
|
954
|
56
|
71
|
84
|
84
|
84
|
|